We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
(+6.9%)
Cap. Flow
-$507M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$526M |
| 2 |
Ally Financial
ALLY
|
+$198M |
| 3 |
CSX Corp
CSX
|
+$191M |
| 4 |
NetEase
NTES
|
+$173M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$262M |
| 2 |
CVS Health
CVS
|
+$240M |
| 3 |
Mastercard
MA
|
+$204M |
| 4 |
McKesson
MCK
|
+$201M |
| 5 |
Molson Coors Class B
TAP
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.15% |
| 4 | Financials | 10.5% |
| 5 | Energy | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBT
1
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $985M | 2.06% |
49,912,315
+1,192,640
| +2% | +$21.3M |
|
2
Baidu
BIDU
$36.5B
| $917M | 1.92% |
4,907,001
+114,934
| +2% | +$18.8M |
|
3
Apple
AAPL
$4.72T
| $904M | 1.89% |
38,911,044
+2,227,684
| +6% | +$47.4M |
|
4
Telkom Indonesia
TLK
$14.2B
| $862M | 1.8% |
41,403,178
-5,989,712
| -13% | -$124M |
|
|
VIAB
5
DELISTED
Viacom Inc. Class B
VIAB
| $840M | 1.76% |
9,689,296
-566,640
| -6% | -$48.1M |
|
|
CHL
6
DELISTED
China Mobile Limited
CHL
| $840M | 1.76% |
17,274,679
+302,615
| +2% | +$14.5M |
|
7
Pfizer
PFE
$143B
| $825M | 1.72% |
29,295,658
+2,637,816
| +10% | +$75.2M |
|
|
8
Teva Pharmaceuticals
TEVA
$36.3B
| $801M | 1.67% |
15,283,002
+10,288,361
| +206% | +$526M |
|
9
Cisco
CSCO
$444B
| $763M | 1.59% |
30,690,326
+26,794
| +0.1% | +$639K |
|
|
10
NetEase
NTES
$76.9B
| $750M | 1.57% |
47,857,270
+12,110,000
| +34% | +$173M |
|
11
TSMC
TSM
$2.16T
| $748M | 1.56% |
34,991,041
+255,664
| +0.7% | +$5.27M |
|
12
Zoetis
ZTS
$31.3B
| $727M | 1.52% |
22,529,823
+3,759,441
| +20% | +$115M |
|
13
Advance Auto Parts
AAP
$3.22B
| $719M | 1.5% |
5,328,309
+493,574
| +10% | +$61.1M |
|
14
PLDT
PHI
$4.17B
| $691M | 1.44% |
10,257,785
+144,766
| +1% | +$9.4M |
|
|
EMC
15
DELISTED
EMC CORPORATION
EMC
| $614M | 1.28% |
23,315,727
+279,154
| +1% | +$7.37M |
|
|
16
Molson Coors Class B
TAP
$7.51B
| $607M | 1.27% |
8,180,114
-2,650,775
| -24% | -$171M |
|
17
Microsoft
MSFT
$2.83T
| $555M | 1.16% |
13,298,945
+485,086
| +4% | +$19.6M |
|
18
Alphabet (Google) Class C
GOOG
$3.89T
| $554M | 1.16% |
19,157,734
+912,963
| +5% | +$24.8M |
|
19
YPF
YPF
$20.4B
| $534M | 1.12% |
16,329,265
-2,260,646
| -12% | -$69.1M |
|
20
Visa
V
$669B
| $529M | 1.11% |
10,049,384
+446,388
| +5% | +$23.3M |
|
21
Ambev
ABEV
$47.7B
| $523M | 1.09% |
74,259,953
+1,755,539
| +2% | +$12.9M |
|
22
Chevron
CVX
$387B
| $508M | 1.06% |
3,889,424
+533,160
| +16% | +$66.3M |
|
|
23
McKesson
MCK
$96.5B
| $482M | 1.01% |
2,588,185
-1,128,858
| -30% | -$201M |
|
|
24
CSX Corp
CSX
$97.8B
| $476M | 0.99% |
46,345,137
+19,618,296
| +73% | +$191M |
|
25
Eastman Chemical
EMN
$7.77B
| $447M | 0.93% |
5,117,559
-184,547
| -3% | -$16M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.
- Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
- Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
- Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
- Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
- Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
- Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
- Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.
Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.